PMC4684617_01
Intraoperative tissue changes. Figure depicting intraoperative tissue changes identified using the integrated ultrasound imaging transducer of the Sonablate  500 HIFU device. Visualisation of hyperechoic transformation at the target site confirms tissue ablation. a Transverse and sagittal still images of the cervical tumour depicting HIFU treatment planning. b Transverse and sagittal still images of the cervical tumour demonstrating post-ablational hyperechoic effects, signifying effective ablation
40349_2015_43_Fig1_HTML.jpg
PMC4684617_01_40349_2015_43_Fig1_HTML.jpg
Fig1
Hyperechoic greyscale changes and gas formation, representing ablative effects, were visualised using the real-time integrated ultrasound imaging to monitor for the presence of tissue destruction (Fig. 1).
Pre- and post-treatment MRI changes. Axial T2-weighted MRI at the level of the pelvic side wall showing the primary cervical tumour at baseline (a) and post-treatment (b). A significant tumour burden remains, although, the AP length of the lesion has reduced in size from 4.5 to 3.4 cm
40349_2015_43_Fig2_HTML.jpg
PMC4684617_01_40349_2015_43_Fig2_HTML.jpg
Fig2
Baseline and post-therapy imaging is shown in Fig. 2.